✦ LIBER ✦

Phase II study of alpha interferon on renal cell carcinoma. Summary of three collaborative trials

✍ Scribed by Takashi Umeda; Tadao Niijima

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 505 KB
Volume: 58
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19860915)58:6<1231::aid-cncr2820580610>3.0.co;2-#

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of recombinant human inte

Phase II study of recombinant human interferon gamma (S-6810) on renal cell carcinoma. Summary of two collaborative studies

✍ RECOMBINANT HUMAN INTERFERON GAMMA (S-6810) RESEARCH GROUP ON RENAL CELL CARCINO 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB 👁 1 views

A phase II trial of interferon alpha-2A

A phase II trial of interferon alpha-2A plus fluorouracil in advanced renal cell carcinoma

✍ Brian R. Murphy; Susan M. Rynard; Lawrence H. Einhorn; Patrick J. Loehrer 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 499 KB

Phase I/II study of recombinant interfer

Phase I/II study of recombinant interferon α and γ in advanced progressive renal-cell carcinoma

✍ Pieter H. M. de Mulder; Frans M. J. Debruyne; Mart P. H. Franssen; Arno D. H. Ge 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 585 KB

Sequential administration of interferon

Sequential administration of interferon γ and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial

✍ Manuela Schmidinger; Günther G. Steger; Catharina Wenzel; Gottfried J. Locker; T 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 111 KB

Modulation of human lymphoblastoid inter

Modulation of human lymphoblastoid interferon activity by melatonin in metastatic renal cell carcinoma. A phase II study

✍ Bruno Neri; Carlo Fiorelli; Fausto Moroni; Giulio Nicita; Maria Cristina Paolett 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 3 views

A phase II trial of interferon-α and 5-f

A phase II trial of interferon-α and 5-fluorouracil in patients with advanced renal cell carcinoma: A Southwest Oncology Group study

✍ Laurence Elias; Brent A. Blumenstein; Julie Kish; Robert C. Flanigan; James L. W 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 1 views

## BACKGROUND. Renal cell carcinoma is a common neoplasm that is often refractory to treatment. It is occasionally responsive to immunoniodulating agents including interferon-a, which enhances the effects of 5-fluorouracil upon cells. Combinations of these two drugs have been most frequently tested